查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1986309

全球女性健康市場：市場規模、佔有率和趨勢分析（按應用、藥物類別、年齡層和地區分類），細分市場預測（2026-2033 年）

Women's Health Market Size, Share & Trends Analysis Report By Application, By Drug Class, By Age, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

女性健康市場概覽

2025年全球女性健康市場規模估計為534.8億美元，預計2033年將達到754.2億美元。

預計從 2026 年到 2033 年，該市場將以 5.1% 的複合年成長率成長。市場成長要素包括老年女性人口的增加以及女性健康領域新的先進治療方法的推出。

此外，世界各國政府為改善女性健康和意識提升而採取的支持措施預計將在預測期內推動市場成長。女性健康市場正日益採用生命週期視角進行定義，不僅涵蓋生殖醫學，還包括孕產婦健康、生育治療、更年期管理和性別特異性診斷。各國政府和多邊組織正將女性健康置於其醫療保健系統的優先事項地位，並在世界各個層面影響監管、報銷和資金方面的調整。世界衛生組織（世衛組織）持續強調性與生殖健康和權利是衛生系統韌性和公平性的基礎，這正在塑造全球政策議程。

監管機構對安全性、證據生成以及女性在各個生命階段參與臨床研究的監管力度正在加強。這一點在荷爾蒙療法和更年期護理等領域尤其明顯。這直接影響到申請開發策略、核准流程和上市後監測的要求。同時，醫療保健相關企業在其年度報告和投資者溝通中，將女性健康定位為策略成長和責任領域，並強調將更加關注診斷、生育技術和慢性病管理。

總體而言，該市場正受到政策參與度提高、監管預期轉變以及企業策略投資的影響，機會集中在循證治療方法、診斷和與公共衛生優先事項相一致的可擴展護理模式上。

目錄

第1章：分析方法和範圍

第2章執行摘要

第3章：女性健康市場：影響因素、趨勢與範圍

  • 市場展望
  • 市場動態
  • 商業環境分析
    • 產業分析：波特五力分析
    • PESTLE分析
    • 管道分析

第4章：女性健康市場：按應用領域進行業務分析

  • 按應用領域分類的市場佔有率（2025 年和 2033 年）
  • 市場規模、預測與趨勢分析：按應用領域分類（2021-2033 年）
  • 荷爾蒙引起的不孕症
  • 避孕藥
  • 停經後骨質疏鬆症
  • 子宮內膜異位症/子宮肌瘤
  • 停經
  • 卵巢症候群（PCOS）

第5章：女性健康市場：依藥物類別進行業務分析

  • 按藥物類別分類的市場佔有率（2025 年和 2033 年）
  • 市場規模及預測/趨勢分析：依藥物類別分類（2021-2033 年）
  • 荷爾蒙療法
  • 骨骼健康醫學
  • 不孕症藥物
  • GnRH調變器
  • 疼痛管理，症狀管理
  • 代謝藥物
  • 其他

第6章：女性健康市場：依年齡層別分類的業務分析

  • 按年齡層別分類的市場佔有率（2025 年和 2033 年）
  • 市場規模、預測與趨勢分析：按年齡層別分類（2021-2033 年）
  • 超過50歲
  • 其他

第7章：女性健康市場：區域估算與趨勢分析

  • 市場佔有率分析：按地區分類（2025 年和 2033 年）
  • 市場概覽：按地區
  • 市場規模及預測/趨勢分析（2021-2033）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭情勢

  • 參與企業概況
  • 企業市場分析
  • 公司分類
  • 策略藍圖
  • 公司簡介/列表
    • AbbVie, Inc.
    • Bayer AG
    • Organon &Co.
    • Pfizer, Inc.
    • Agile Therapeutics
    • Amgen, Inc.
    • Apothecus Pharmaceutical Corp.
    • Blairex Laboratories, Inc.
    • Ferring
    • Theramex
Product Code: GVR-1-68038-634-9

Women's Health Market Summary

The global women's health market size was estimated at USD 53.48 billion in 2025 and is projected to reach USD 75.42 billion by 2033, growing at a CAGR of 5.1% from 2026 to 2033. Market growth can be attributed to the increase in the geriatric population of women and the introduction of new advanced therapeutic applications for women's health.

Furthermore, favorable policies initiated by governments to improve women's health and raise awareness are likely to drive market growth during the forecast period. The market for women s health is increasingly defined by a lifecycle approach that extends beyond reproductive care to include maternal health, fertility, menopause management, and gender specific diagnostics. Governments and multilateral agencies are reinforcing women's health as a health system priority, influencing regulation, reimbursement, and funding alignment across regions. World Health Organization continues to emphasize sexual and reproductive health and rights as foundational to health system resilience and equity, shaping policy agendas globally.

Regulatory scrutiny has intensified around safety, evidence generation, and inclusion of women across life stages in clinical research, particularly in areas such as hormone therapies and menopause care. This has direct implications for application development strategies, labeling pathways, and post market surveillance requirements. In parallel, healthcare companies are positioning women's health as a strategic growth and responsibility area within annual reports and investor communications, highlighting increased focus on diagnostics, fertility technologies, and chronic condition management.

Overall, the market is shaped by rising policy engagement, evolving regulatory expectations, and strategic corporate investment, with opportunities centered on evidence backed therapies, diagnostics, and scalable care models aligned with public health priorities.

Global Women's Health Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global women's health market report based on application, drug class, age, and region:

  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Hormonal Infertility
  • Contraceptives
  • Postmenopausal Osteoporosis
  • Endometriosis & Uterine Fibroids
  • Menopause
  • Polycystic Ovary Syndrome (PCOS)
  • Drug Class Outlook (Revenue, USD Million, 2021 - 2033)
  • Hormonal Therapies
  • Bone Health Agents
  • Fertility Agents
  • GnRH Modulators
  • Pain and Symptom Management
  • Metabolic Agents
  • Others
  • Age Outlook (Revenue, USD Million, 2021 - 2033)
  • 50 years and above
    • Postmenopausal Osteoporosis
    • Endometriosis & Uterine Fibroids
    • Menopause
    • Others
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
  • Thailand
    • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Application
    • 1.2.2. Drug Class
    • 1.2.3. Age
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Women's Health Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Pipeline Analysis

Chapter 4. Women's Health Market: Application Business Analysis

  • 4.1. Application Market Share, 2025 & 2033
  • 4.2. Application Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 4.4. Hormonal Infertility
    • 4.4.1. Hormonal Infertility Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Contraceptives
    • 4.5.1. Contraceptives Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Postmenopausal Osteoporosis
    • 4.6.1. Postmenopausal Osteoporosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Endometriosis & Uterine Fibroids
    • 4.7.1. Endometriosis & Uterine Fibroids Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8. Menopause
    • 4.8.1. Menopause Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.9. Polycystic Ovary Syndrome (PCOS)
    • 4.9.1. Polycystic Ovary Syndrome (PCOS) Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Women's Health Market: Drug Class Business Analysis

  • 5.1. Drug Class Market Share, 2025 & 2033
  • 5.2. Drug Class Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2021 to 2033 (USD Million)
  • 5.4. Hormonal Therapies
    • 5.4.1. Hormonal Therapies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Bone Health Agents
    • 5.5.1. Bone Health Agents Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Fertility Agents
    • 5.6.1. Fertility Agents Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. GnRH Modulators
    • 5.7.1. GnRH Modulators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Pain and Symptom Management
    • 5.8.1. Pain and Symptom Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.9. Metabolic Agents
    • 5.9.1. Metabolic Agents Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.10. Others
    • 5.10.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Women's Health Market: Age Business Analysis

  • 6.1. Age Market Share, 2025 & 2033
  • 6.2. Age Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 6.4. 50 years and above
    • 6.4.1. 50 years and above Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.2. Postmenopausal Osteoporosis
      • 6.4.2.1. Postmenopausal Osteoporosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Endometriosis & Uterine Fibroids
      • 6.4.3.1. Endometriosis & Uterine Fibroids Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. Menopause
      • 6.4.4.1. Menopause Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.5. Others
      • 6.4.5.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Others
    • 6.5.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Women's Health Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2025 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 7.4. North America
    • 7.4.1. North America Women's Health Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Type Disease Prevalence
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Reimbursement Framework
      • 7.4.2.5. U.S. Women's Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Type Disease Prevalence
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Reimbursement Framework
      • 7.4.3.5. Canada Women's Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Type Disease Prevalence
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Reimbursement Framework
      • 7.4.4.5. Mexico Women's Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Women's Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Type Disease Prevalence
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement Framework
      • 7.5.2.5. Uk Women's Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Type Disease Prevalence
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement Framework
      • 7.5.3.5. Germany Women's Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Type Disease Prevalence
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Reimbursement Framework
      • 7.5.4.5. France Women's Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Type Disease Prevalence
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Reimbursement Framework
      • 7.5.5.5. Italy Women's Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Type Disease Prevalence
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Reimbursement Framework
      • 7.5.6.5. Spain Women's Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Type Disease Prevalence
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Reimbursement Framework
      • 7.5.7.5. Denmark Women's Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Type Disease Prevalence
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Reimbursement Framework
      • 7.5.8.5. Sweden Women's Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Type Disease Prevalence
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Reimbursement Framework
      • 7.5.9.5. Norway Women's Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Women's Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Type Disease Prevalence
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement Framework
      • 7.6.2.5. Japan Women's Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Type Disease Prevalence
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement Framework
      • 7.6.3.5. China Women's Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Type Disease Prevalence
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement Framework
      • 7.6.4.5. India Women's Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Type Disease Prevalence
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement Framework
      • 7.6.5.5. Australia Women's Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Type Disease Prevalence
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Reimbursement Framework
      • 7.6.6.5. South Korea Women's Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Type Disease Prevalence
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Reimbursement Framework
      • 7.6.7.5. Thailand Women's Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Women's Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Type Disease Prevalence
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Reimbursement Framework
      • 7.7.2.5. Brazil Women's Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Type Disease Prevalence
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Reimbursement Framework
      • 7.7.3.5. Argentina Women's Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Middle East and Africa
    • 7.8.1. Middle East and Africa Women's Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Type Disease Prevalence
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Reimbursement Framework
      • 7.8.2.5. South Africa Women's Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Type Disease Prevalence
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Reimbursement Framework
      • 7.8.3.5. Saudi Arabia Women's Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Type Disease Prevalence
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. Reimbursement Framework
      • 7.8.4.5. UAE Women's Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Type Disease Prevalence
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Reimbursement Framework
      • 7.8.5.5. Kuwait Women's Health Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. AbbVie, Inc.
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Application Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Bayer AG
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Application Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Organon & Co.
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Application Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Pfizer, Inc.
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Application Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Agile Therapeutics
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Application Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Amgen, Inc.
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Application Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Apothecus Pharmaceutical Corp.
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Application Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Blairex Laboratories, Inc.
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Application Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. Ferring
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Application Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Theramex
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Application Benchmarking
      • 8.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global Women's Health Market, by Region, 2021 - 2033 (USD Million)
  • Table 4 Global Women's Health Market, by Application, 2021 - 2033 (USD Million)
  • Table 5 Global Women's Health Market, by Drug Class, 2021 - 2033 (USD Million)
  • Table 6 Global Women's Health Market, by Age, 2021 - 2033 (USD Million)
  • Table 7 North America Women's Health Market, by Country, 2021 - 2033 (USD Million)
  • Table 8 North America Women's Health Market, by Application, 2021 - 2033 (USD Million)
  • Table 9 North America Women's Health Market, by Drug Class, 2021 - 2033 (USD Million)
  • Table 10 North America Women's Health Market, by Age, 2021 - 2033 (USD Million)
  • Table 11 U.S. Women's Health Market, by Application, 2021 - 2033 (USD Million)
  • Table 12 U.S. Women's Health Market, by Drug Class, 2021 - 2033 (USD Million)
  • Table 13 U.S. Women's Health Market, by Age, 2021 - 2033 (USD Million)
  • Table 14 Canada Women's Health Market, by Application, 2021 - 2033 (USD Million)
  • Table 15 Canada Women's Health Market, by Drug Class, 2021 - 2033 (USD Million)
  • Table 16 Canada Women's Health Market, by Age, 2021 - 2033 (USD Million)
  • Table 17 Mexico Women's Health Market, by Application, 2021 - 2033 (USD Million)
  • Table 18 Mexico Women's Health Market, by Drug Class, 2021 - 2033 (USD Million)
  • Table 19 Mexico Women's Health Market, by Age, 2021 - 2033 (USD Million)
  • Table 20 Europe Women's Health Market, by Country, 2021 - 2033 (USD Million)
  • Table 21 Europe Women's Health Market, by Application, 2021 - 2033 (USD Million)
  • Table 22 Europe Women's Health Market, by Drug Class, 2021 - 2033 (USD Million)
  • Table 23 Europe Women's Health Market, by Age, 2021 - 2033 (USD Million)
  • Table 24 UK Women's Health Market, by Application, 2021 - 2033 (USD Million)
  • Table 25 UK Women's Health Market, by Drug Class, 2021 - 2033 (USD Million)
  • Table 26 UK Women's Health Market, by Age, 2021 - 2033 (USD Million)
  • Table 27 Germany Women's Health Market, by Application, 2021 - 2033 (USD Million)
  • Table 28 Germany Women's Health Market, by Drug Class, 2021 - 2033 (USD Million)
  • Table 29 Germany Women's Health Market, by Age, 2021 - 2033 (USD Million)
  • Table 30 France Women's Health Market, by Application, 2021 - 2033 (USD Million)
  • Table 31 France Women's Health Market, by Drug Class, 2021 - 2033 (USD Million)
  • Table 32 France Women's Health Market, by Age, 2021 - 2033 (USD Million)
  • Table 33 Italy Women's Health Market, by Application, 2021 - 2033 (USD Million)
  • Table 34 Italy Women's Health Market, by Drug Class, 2021 - 2033 (USD Million)
  • Table 35 Italy Women's Health Market, by Age, 2021 - 2033 (USD Million)
  • Table 36 Spain Women's Health Market, by Application, 2021 - 2033 (USD Million)
  • Table 37 Spain Women's Health Market, by Drug Class, 2021 - 2033 (USD Million)
  • Table 38 Spain Women's Health Market, by Age, 2021 - 2033 (USD Million)
  • Table 39 Denmark Women's Health Market, by Application, 2021 - 2033 (USD Million)
  • Table 40 Denmark Women's Health Market, by Drug Class, 2021 - 2033 (USD Million)
  • Table 41 Denmark Women's Health Market, by Age, 2021 - 2033 (USD Million)
  • Table 42 Norway Women's Health Market, by Application, 2021 - 2033 (USD Million)
  • Table 43 Norway Women's Health Market, by Drug Class, 2021 - 2033 (USD Million)
  • Table 44 Norway Women's Health Market, by Age, 2021 - 2033 (USD Million)
  • Table 45 Sweden Women's Health Market, by Application, 2021 - 2033 (USD Million)
  • Table 46 Sweden Women's Health Market, by Drug Class, 2021 - 2033 (USD Million)
  • Table 47 Sweden Women's Health Market, by Age, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific Women's Health Market, by Country, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific Women's Health Market, by Application, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific Women's Health Market, by Drug Class, 2021 - 2033 (USD Million)
  • Table 51 Asia Pacific Women's Health Market, by Age, 2021 - 2033 (USD Million)
  • Table 52 Japan Women's Health Market, by Application, 2021 - 2033 (USD Million)
  • Table 53 Japan Women's Health Market, by Drug Class, 2021 - 2033 (USD Million)
  • Table 54 Japan Women's Health Market, by Age, 2021 - 2033 (USD Million)
  • Table 55 China Women's Health Market, by Application, 2021 - 2033 (USD Million)
  • Table 56 China Women's Health Market, by Drug Class, 2021 - 2033 (USD Million)
  • Table 57 China Women's Health Market, by Age, 2021 - 2033 (USD Million)
  • Table 58 India Women's Health Market, by Application, 2021 - 2033 (USD Million)
  • Table 59 India Women's Health Market, by Drug Class, 2021 - 2033 (USD Million)
  • Table 60 India Women's Health Market, by Age, 2021 - 2033 (USD Million)
  • Table 61 South Korea Women's Health Market, by Application, 2021 - 2033 (USD Million)
  • Table 62 South Korea Women's Health Market, by Drug Class, 2021 - 2033 (USD Million)
  • Table 63 South Korea Women's Health Market, by Age, 2021 - 2033 (USD Million)
  • Table 64 Australia Women's Health Market, by Application, 2021 - 2033 (USD Million)
  • Table 65 Australia Women's Health Market, by Drug Class, 2021 - 2033 (USD Million)
  • Table 66 Australia Women's Health Market, by Age, 2021 - 2033 (USD Million)
  • Table 67 Thailand Women's Health Market, by Application, 2021 - 2033 (USD Million)
  • Table 68 Thailand Women's Health Market, by Drug Class, 2021 - 2033 (USD Million)
  • Table 69 Thailand Women's Health Market, by Age, 2021 - 2033 (USD Million)
  • Table 70 Latin America Women's Health Market, by Country, 2021 - 2033 (USD Million)
  • Table 71 Latin America Women's Health Market, by Application, 2021 - 2033 (USD Million)
  • Table 72 Latin America Women's Health Market, by Drug Class, 2021 - 2033 (USD Million)
  • Table 73 Latin America Women's Health Market, by Age, 2021 - 2033 (USD Million)
  • Table 74 Brazil Women's Health Market, by Application, 2021 - 2033 (USD Million)
  • Table 75 Brazil Women's Health Market, by Drug Class, 2021 - 2033 (USD Million)
  • Table 76 Brazil Women's Health Market, by Age, 2021 - 2033 (USD Million)
  • Table 77 Argentina Women's Health Market, by Application, 2021 - 2033 (USD Million)
  • Table 78 Argentina Women's Health Market, by Drug Class, 2021 - 2033 (USD Million)
  • Table 79 Argentina Women's Health Market, by Age, 2021 - 2033 (USD Million)
  • Table 80 Middle East & Africa Women's Health Market, by Country, 2021 - 2033 (USD Million)
  • Table 81 Middle East & Africa Women's Health Market, by Application, 2021 - 2033 (USD Million)
  • Table 82 Middle East & Africa Women's Health Market, by Drug Class, 2021 - 2033 (USD Million)
  • Table 83 Middle East & Africa Women's Health Market, by Age, 2021 - 2033 (USD Million)
  • Table 84 South Africa Women's Health Market, by Application, 2021 - 2033 (USD Million)
  • Table 85 South Africa Women's Health Market, by Drug Class, 2021 - 2033 (USD Million)
  • Table 86 South Africa Women's Health Market, by Age, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia Women's Health Market, by Application, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia Women's Health Market, by Drug Class, 2021 - 2033 (USD Million)
  • Table 89 Saudi Arabia Women's Health Market, by Age, 2021 - 2033 (USD Million)
  • Table 90 UAE Women's Health Market, by Application, 2021 - 2033 (USD Million)
  • Table 91 UAE Women's Health Market, by Drug Class, 2021 - 2033 (USD Million)
  • Table 92 UAE Women's Health Market, by Age, 2021 - 2033 (USD Million)
  • Table 93 Kuwait Women's Health Market, by Application, 2021 - 2033 (USD Million)
  • Table 94 Kuwait Women's Health Market, by Drug Class, 2021 - 2033 (USD Million)
  • Table 95 Kuwait Women's Health Market, by Age, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Women's Health
  • Fig. 14 Parent market outlook
  • Fig. 15 Related/ancillary market outlook
  • Fig. 16 Penetration and growth prospect mapping
  • Fig. 17 Industry value chain analysis
  • Fig. 18 Women's Health driver impact
  • Fig. 19 Women's Health restraint impact
  • Fig. 20 Women's Health strategic initiatives analysis
  • Fig. 21 Women's Health: Application movement analysis
  • Fig. 22 Women's Health: Application outlook and key takeaways
  • Fig. 23 Hormonal Infertility market estimates and forecast, 2021 - 2033
  • Fig. 24 Contraceptives market estimates and forecast, 2021 - 2033
  • Fig. 25 Postmenopausal Osteoporosis market estimates and forecast, 2021 - 2033
  • Fig. 26 Endometriosis & Uterine Fibroids market estimates and forecast, 2021 - 2033
  • Fig. 27 Menopause market estimates and forecast, 2021 - 2033
  • Fig. 28 Polycystic Ovary Syndrome (PCOS) market estimates and forecast, 2021 - 2033
  • Fig. 29 Women's Health: Drug Class movement analysis
  • Fig. 30 Women's Health: Drug Class outlook and key takeaways
  • Fig. 31 Hormonal Therapies market estimates and forecast, 2021 - 2033
  • Fig. 32 Bone Health Agents market estimates and forecast, 2021 - 2033
  • Fig. 33 Fertility Agents market estimates and forecast, 2021 - 2033
  • Fig. 34 GnRH Modulators market estimates and forecast, 2021 - 2033
  • Fig. 35 Pain and Symptom Management market estimates and forecast, 2021 - 2033
  • Fig. 36 Metabolic Agents market estimates and forecast, 2021 - 2033
  • Fig. 37 Others market estimates and forecast, 2021 - 2033
  • Fig. 38 Women's Health: Age movement analysis
  • Fig. 39 Women's Health: Age outlook and key takeaways
  • Fig. 40 50 years and above market estimates and forecast, 2021 - 2033
  • Fig. 41 Postmenopausal Osteoporosis market estimates and forecast, 2021 - 2033
  • Fig. 42 Endometriosis & Uterine Fibroids market estimates and forecast, 2021 - 2033
  • Fig. 43 Menopause market estimates and forecast, 2021 - 2033
  • Fig. 44 Others market estimates and forecast, 2021 - 2033
  • Fig. 45 Others market estimates and forecast, 2021 - 2033
  • Fig. 46 Women's Health: Regional movement analysis
  • Fig. 47 Women's Health: Regional outlook and key takeaways
  • Fig. 48 Women's Health share and leading players
  • Fig. 49 North America Women's Health market share and leading players
  • Fig. 50 Europe Women's Health market share and leading players
  • Fig. 51 Asia Pacific Women's Health market share and leading players
  • Fig. 52 Latin America Women's Health market share and leading players
  • Fig. 53 Middle East & Africa Women's Health market share and leading players
  • Fig. 54 North America Women's Health Market SWOT Analysis
  • Fig. 55 Europe Women's Health Market SWOT Analysis
  • Fig. 56 Asia Pacific Women's Health Market SWOT Analysis
  • Fig. 57 Latin America Women's Health Market SWOT Analysis
  • Fig. 58 Middle East & Africa Women's Health Market SWOT Analysis
  • Fig. 59 North America Women's Health Market Analysis, by country
  • Fig. 60 North America
  • Fig. 61 North America Women's Health Market Estimates and Forecasts 2021 - 2033
  • Fig. 62 U.S.
  • Fig. 63 U.S. Women's Health Market Estimates and Forecasts 2021 - 2033
  • Fig. 64 Canada
  • Fig. 65 Canada Women's Health Market Estimates and Forecasts 2021 - 2033
  • Fig. 66 Mexico
  • Fig. 67 Mexico Women's Health Market Estimates and Forecasts 2021 - 2033
  • Fig. 68 Europe
  • Fig. 69 Europe Women's Health Market Estimates and Forecasts 2021 - 2033
  • Fig. 70 UK
  • Fig. 71 UK Women's Health Market Estimates and Forecasts 2021 - 2033
  • Fig. 72 Germany
  • Fig. 73 Germany Women's Health Market Estimates and Forecasts 2021 - 2033
  • Fig. 74 France
  • Fig. 75 France Women's Health Market Estimates and Forecasts 2021 - 2033
  • Fig. 76 Italy
  • Fig. 77 Italy Women's Health Market Estimates and Forecasts 2021 - 2033
  • Fig. 78 Spain
  • Fig. 79 Spain Women's Health Market Estimates and Forecasts 2021 - 2033
  • Fig. 80 Denmark
  • Fig. 81 Denmark Women's Health Market Estimates and Forecasts 2021 - 2033
  • Fig. 82 Sweden
  • Fig. 83 Sweden Women's Health Market Estimates and Forecasts 2021 - 2033
  • Fig. 84 Norway
  • Fig. 85 Norway Women's Health Market Estimates and Forecasts 2021 - 2033
  • Fig. 86 Asia Pacific
  • Fig. 87 Asia Pacific Women's Health Market Estimates and Forecasts 2021 - 2033
  • Fig. 88 China
  • Fig. 89 China Women's Health Market Estimates and Forecasts 2021 - 2033
  • Fig. 90 Japan
  • Fig. 91 Japan Women's Health Market Estimates and Forecasts 2021 - 2033
  • Fig. 92 India
  • Fig. 93 India Women's Health Market Estimates and Forecasts 2021 - 2033
  • Fig. 94 Thailand
  • Fig. 95 Thailand Women's Health Market Estimates and Forecasts 2021 - 2033
  • Fig. 96 South Korea
  • Fig. 97 South Korea Women's Health Market Estimates and Forecasts 2021 - 2033
  • Fig. 98 Australia
  • Fig. 99 Australia Women's Health Market Estimates and Forecasts 2021 - 2033
  • Fig. 100 Latin America
  • Fig. 101 Latin America Women's Health Market Estimates and Forecasts 2021 - 2033
  • Fig. 102 Brazil
  • Fig. 103 Brazil Women's Health Market Estimates and Forecasts 2021 - 2033
  • Fig. 104 Argentina
  • Fig. 105 Argentina Women's Health Market Estimates and Forecasts 2021 - 2033
  • Fig. 106 Middle East & Africa
  • Fig. 107 Middle East & Africa Women's Health Market Estimates and Forecasts 2021 - 2033
  • Fig. 108 South Africa
  • Fig. 109 South Africa Women's Health Market Estimates and Forecasts 2021 - 2033
  • Fig. 110 Saudi Arabia
  • Fig. 111 Saudi Arabia Women's Health Market Estimates and Forecasts 2021 - 2033
  • Fig. 112 UAE
  • Fig. 113 UAE Women's Health Market Estimates and Forecasts 2021 - 2033
  • Fig. 114 Kuwait
  • Fig. 115 Kuwait Women's Health Market Estimates and Forecasts 2021 - 2033
  • Fig. 116 Market share of key market players - Women's Health Market